In December 1997, 170 hemorrhagic fever-associated deaths were reported in Carissa District, Kenya. Laboratory testing identified evidence of acute
Human infection with RVFV was first reported soon after Daubney and colleagues isolated the virus in 1930
The normalized difference vegetation index has a linear relationship to rainfall in semiarid regions such as East Africa.
Images from advanced, very high resolution radiometer instrument on a National Oceanic and Atmospheric Administration satellite comparing normalized difference vegetation index data (as a surrogate for rainfall), from December 1996 (A) and December 1997 (B). Increasing vegetation is depicted from tan to yellow [predominating in part (a)], to light and dark green [predominating in (b)].
After RVFV was identified as the primary cause of this outbreak, an international task force led by the Kenya MOH established surveillance for hemorrhagic fever and other severe manifestations of infection. Because the surveillance system identified only those with severe symptoms, the task force also conducted a cross-sectional study in the human population of the Garissa District to determine the incidence of recent infection with RVFV and to evaluate risk factors for infection.
The investigation was conducted in the Garissa District of the North Eastern Province of Kenya, which borders southern Somalia. In 1998, an estimated 231,022 residents living in Garissa District were distributed among 12 divisions and 84 sublocations (Office of the President, Garissa District Development Plan: 1997-2001, unpub. data). In addition to the Kenyan residents, 120,000 Somali refugees lived in the district in 1998. Garissa has an arid climate with a predominantly flat and grassy landscape. Precipitation in the district averages 250 mm to 500 mm annually, varies considerably from year to year, and occurs in a bimodal pattern with two peaks, in March through May and October through December. Although a number of settled towns are dispersed throughout the region, the rural population is principally composed of nomadic herdsmen.
Two events hampered surveillance. By January 1998, floodwater had damaged or covered most of the already poor roadways in the Garissa District, making them impassable. Investigators required air transportation to perform surveillance. Additionally, a nationwide nurses’ strike in December and January greatly decreased the medical personnel in hospitals and clinics, which contributed to the difficulties in providing patient care and collecting data.
A probable case was defined as someone presenting with fever and bleeding from their gums, nose, eyes, rectum, lungs, or gastrointestinal tract, between October 1997 (the onset of flooding) and February 8, 1998. If specimens were available, diagnostic laboratory tests for RVFV were performed.
In Garissa, active case-finding for hemorrhagic fever was performed by members of local law enforcement, village chiefs, and other government officials. Periodic reports were provided to the district health officers and the task force. We disseminated a case-report form to all district medical officers and international relief agencies involved in medical care in the area. When possible, reports of possible cases were investigated to obtain demographic and clinical information, as well as blood, stool, or tissue specimens. The WHO Hemorrhagic Fever Task Force was conducting similar surveillance throughout Kenya and in southern Somalia and northern Tanzania.
Initially, specimens were transported to the Africa Medical Research Foundation in Nairobi, where serum specimens were centrifuged, divided into aliquots, and forwarded to the Viral Research Center/Kenyan Medical Research Institute. Subsequently, a laboratory operated by Médècins du Monde was established in Garissa to process clinical samples. Within 12 hours of collection, serum specimens were stored at 4°C until packed and shipped to National Institute for Virology and CDC for RVFV-specific IgG and IgM antibody enzyme-linked immunosorbant assay (ELISA), virus isolation, RT-PCR and sequencing of the DNA product, or immunohistochemistry using previously described methods (
For the cross-sectional survey, a laboratory-confirmed case definition was used. A case of recent infection was defined as presence of RVFV-specific IgM antibodies by ELISA. Persons with RVFV-specific IgG antibodies by ELISA and no IgM antibody were considered to have been infected before this outbreak. In our initial calculations, we considered persons with only anti-RVFV IgG antibodies to be protected against infection. The background prevalence of past RVFV infection in Kenya is not known, but IgG positivity as high as 40% has been shown in populations at high risk after epizootics
We selected participants for the cross-sectional survey from the non-refugee population of Garissa District using a modified multistage cluster design
After informed consent was obtained, a blood specimen was collected and each participant was interviewed. We used a standardized questionnaire that included demographic characteristics (age, gender, family size), exposure information (e.g., slaughtering practices, butchering, consuming raw meat and milk), environmental factors (displacement by flood, type of settlement, loss of livestock), and history of illness between the start of the floods and the date of the interview. Exposure to mosquitoes was evaluated through questions about attempts to reduce bites (i.e., mosquito nets, fires, other methods). Otherwise, all persons were assumed to share a similar risk for insect bites. Local health workers fluent in English, Kiswahili, and Somali were trained to administer the questionnaire and were supervised by an epidemiologist. Interviewers recorded information in English.
Blood specimens were kept at ambient temperature for <6 hours. Specimens were processed at the Médècins du Monde laboratory as noted above. RVFV-specific IgG ELISA, as well as IgM ELISA, was performed on all blood specimens. At the time of the cross-sectional survey, there were no reports of severe manifestations of illness and we believed that virus transmission was not ongoing. Therefore, virus isolation and PCR were not performed on these specimens.
Data from completed questionnaires were double-entered into databases by using Epi Info version 6.0 (CDC, Atlanta, GA). Univariate and multivariate analyses were performed by using SAS (version 6.12, Cary, NC). Poisson regression was used with a generalized estimating equations algorithm to control for the clustered nature of the data
The hemorrhagic fever surveillance system identified 77 persons with severe febrile illness in Garissa District whose onset of fever was between November 10, 1997, and February 8, 1998. Fifty-three males (57% male; median age 28 years, from 3 to 85 years) met the case definition for hemorrhagic fever (
Temporal distribution of hemorrhagic fever cases, by date of onset, Garissa District, Kenya, December 1, 1997 to February 14, 1998. Source: Morbidity and Mortality Weekly Report 1998;47:261-4.
| Onset date | Collection date | Virus isolation | RT-PCR | IgM ELISA | IgG ELISA |
|---|---|---|---|---|---|
| 12/9/97 | 12/23/97 | + | + | - | - |
| 12/18/97 | 12/25/97 | + | + | + | - |
| 12/18/97 | 12/26/97 | - | Not done | + | + |
| 12/19/97 | 12/26/97 | + | + | + | + |
| 12/21/97 | 12/26/97 | + | + | + | - |
| 12/22/97 | 01/22/98 | Not done | Not done | + | + |
| 12/30/97 | 01/23/98 | Not done | + | + | + |
| 1/18/98 | 01/22/98 | Not done | - | + | + |
| 1/28/98 | 02/02/98 | Not done | Not done | + | + |
| 2/7/98 | 02/09/98 | Not done | Not done | + | - |
RT-PCR=reverse transcription-polymerase chain reaction; IG=immunoglobulin; ELISA=enzyme-linked immunosorbent assay.
Geographic distribution of Rift Valley fever outbreak, East Africa, 1997-98. (Number of confirmed cases / number of cases with severe febrile illness reported to surveillance system). Source: Morbidity and Mortality Weekly Report 1998;47:261-4.
Of the 202 persons enrolled in the cross-sectional study, 31 (15%) were positive only for anti-RVFV IgG (i.e., previously infected). Although persons having only IgG antibody were widely dispersed geographically, the highest prevalence was found in the Hulugho Division (32%) and the Masalani Division (29%). The highest percentage of previous infection by age group was for persons ³65 years of age (
| Characteristic | Total (%) n = 202 | Priora infection (% of total) n=31 | Susceptibleb n=171 | Acutec infection (% of susceptible) n=31 |
|---|---|---|---|---|
| Age group (years) | ||||
| <15 | 40 (20) | 2 (5) | 38 | 2 (5) |
| 15 to 65 | 150 (74) | 25 (17) | 125 | 28 (22) |
| >65 | 12 (6) | 4 (33) | 8 | 1 (13) |
| Sex | ||||
| Male | 103 (51) | 16 (16) | 87 | 18 (21) |
| Female | 99 (49) | 15 (15) | 84 | 13 (15) |
| Rural habitation | 161 (80) | 25 (16) | 136 | 30 (22) |
| Household >4 persons | 74 (37) | 10 (14) | 64 | 21 (33) |
aAnti-RVF IgG antibody-positive (no immunoglobulin M [IgM]).
bTotal screened minus those with prior infection.
cAnti-
Of the 171 susceptible persons in the sample, 31 (18%) were positive for anti-RVFV IgM. The percentage of those with detectable IgM antibody varied with age; this antibody was detected in 5% of children <15 years of age, 23% of persons 15 to 65 years of age, and 13% of persons >65 (
Assuming an age-adjusted IgM antibody prevalence of 14% in the susceptible population, we estimate that approximately 27,500 persons were infected with RVFV during this outbreak in Garissa District alone. If the presence of IgG antibody were included in the case definition for recent infection, then the standardized prevalence would increase to 23% (95% CI 20-26) and would represent approximately 53,000 infected residents.
Certain demographic characteristics (
| Acutea infection (%) n = 31 | No infection (%) n = 140 | Relative risk | 95% CI | |
|---|---|---|---|---|
| Animal exposures | ||||
| Sheltered livestock in home after flood | 27 (87) | 63 (45) | 5.3 | 2.3-12.6 |
| Killed an animal | 20 (64) | 47 (34) | 2.4 | 1.3-4.3 |
| Butchered an animal | 14 (45) | 33 (24) | 2.0 | 1.1-3.6 |
| Skinned an animal | 20 (65) | 38 (27) | 2.4 | 1.6-3.5 |
| Cooked with meat | 20 (65) | 48 (34) | 2.3 | 1.1-4.9 |
| Milked animals | 25 (80) | 59 (42) | 3.8 | 1.9-7.7 |
| Drank raw animal milk | 30 (97) | 89 (64) | 8.6 | 2.0-36.0 |
| Care of animal during birth | 21 (68) | 46 (33) | 2.6 | 1.4-4.9 |
| Disposal of aborted fetus | 19 (61) | 36 (26) | 2.8 | 1.5-5.5 |
| Sheep contactb | 25 (81) | 48 (29) | 6.3 | 2.9-14.0 |
| Goat contactb | 28 (90) | 91 (65) | 3.1 | 1.6-6.4 |
| Cow contactb | 20 (65) | 49 (35) | 2.4 | 1.3-4.5 |
| Camel contactb | 5 (16) | 17 (12) | 1.3 | 0.5-3.8 |
| Non-animal exposures | ||||
| Home flooded since November 1997 | 25 (81) | 103 (73) | 1.3 | 0.8-2.1 |
| Ill family member | 7 (23) | 20 (14) | 1.6 | 0.8-3.1 |
| Contact with a dead human body | 6 (21) | 10 (7) | 2.2 | 1.0-4.6 |
| Use mosquito nets | 19 (61) | 102 (73) | 0.7 | 0.3-1.4 |
aAnti-
bContact includes herding, cooking, slaughtering or other body fluid contact (except consumption), drinking raw milk.
Many of the animal contact variables were highly associated with infection in univariate analysis, but were also highly colinear. Multivariate analysis of composite variables for species-specific activities that resulted in similar exposures and potential confounders demonstrated a significant association between recent RVFV infection and persons who had contact with sheep blood, amniotic fluid, or milk (not including milk consumption; RR 3.0, 95% CI 1.3-6.7) (
| Exposure | Relative risk | 95% CI |
|---|---|---|
| Contact with sheep blood or body fluids | 3.0 | 1.3-6.7 |
| Sheltering animals in the home | 3.5 | 1.3-9.1 |
| Male gender | 1.6 | 1.0-2.8 |
| Age <15 years | 0.3 | 0.06-1.0 |
| Drinking raw sheep milk | 1.6 | 0.9-2.9 |
When the analysis was repeated using detection of either anti-RVFV IgM or IgG as the outcome variable, which effectively doubled the number of cases of RVFV, only contact with sheep blood or body fluids and sheltering animals in the home remained significantly associated with illness in the multivariate model (data not shown).
After heavy rainfall in late 1997, an epidemic of Rift Valley fever among humans accompanied an epizootic among ungulates in East Africa. From the cross-sectional investigation in the Garissa District of Kenya, we estimated 27,500 recent human infections with the virus occurred during this period, making this the largest outbreak of RVFV infection ever recorded in sub-Saharan Africa. In addition to Garissa District in the North Eastern Province, we identified recent human infection associated with hemorrhagic fever or encephalitis in four of Kenya’s six provinces during the 1997-1998 outbreak (CDC, unpub. data). Surveillance also confirmed human disease in Tanzania, and, for the first time, in Somalia. Risk factors for human infection identified by this study included a broad array of activities associated with animal exposures, but most significantly, contact with sheep (particularly contact with sheep blood or other body fluids), male gender, and housing animals indoors with household members. Children <15 years of age were significantly less likely to have had recent RVFV infection.
Persons identified by the surveillance system did not undergo thorough clinical and laboratory investigations, and most persons who reported hemorrhaging were not directly observed by a clinician. Laboratory testing also found evidence of infection with other viral agents (
In the cross-sectional study, the case definition for recent infection was based on the detection of IgM antibody. Unfortunately, the kinetics of the IgM response to RVFV are not well described. After natural infection, domestic animals lose a detectable amount of IgM antibody within 6 months of infection
All blood specimens for our cross-sectional study were obtained within 12 weeks of the first reported case of hemorrhagic fever in Garissa District. Therefore, the IgM antibodies probably represent recent infection related to the outbreak. If the IgM antibodies disappear quickly, however, the persons in whom we detected only IgG antibody may actually have been infected recently. If we include those persons in the analysis, the incidence of infection could be as high as 23%, representing an additional 25,000 infected persons in Garissa District alone.
Human suffering from RVFV is compounded by the loss of domestic animals. Livestock owners reported losses of approximately 70% of their animals, with the greatest losses among sheep and goats. Other infections thought to contribute to the high illness among livestock during the flooding included nonspecific pneumonia, pasteurellosis, contagious caprine pleuropneumonia, contagious pustular dermatitis, bluetongue, foot rot, and complications of mange (Field Mission of the Food and Agriculture Organization of the United Nations, unpub. data).
Because direct contact with blood or body fluids from viremic animals is an important risk factor for human infection identified by this study, the high number of domestic animal abortions and deaths may have increased the risk for humans developing illness. Many of the early cases were in persons who had recently been involved in the dissection, slaughter, or care of sick animals (
Although any animal that develops a high level of viremia can pose a certain risk for animal-to-human transmission of virus, we found the greatest association with sheep. In past RVFV epizootics, sheep have been the most susceptible domestic animals (
From this study it is not possible to identify which cases were infected by mosquitoes and which through direct contact with animals because we did not gather data on the numbers, species, prevalence of RVFV infection, or biting rates of mosquitos at the time of the outbreak. During February 1998, however, 3,180 mosquitoes were collected from three trapping sites in Garissa District. Of the nine captured species, three have been previously implicated in RVFV transmission to humans (
The probability of recurring outbreaks in East Africa and the potential for spread, by either natural or intentional means, to non-disease endemic areas emphasize the necessity of developing and validating methods to predict, prevent, detect, and treat Rift Valley fever. Remote sensing satellite technology, which can predict rainfall patterns likely to result in disease emergence, has been suggested as a means to monitor RVFV activity (
Suggested citation: Woods CW, Karpati AN, Grein T, McCarthy N, Gaturuku P, Muchiri E. An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98. Emerg Infect Dis. [serial on the Internet]. 2002 Feb [date cited]. Available from
This manuscript is dedicated to the memory of Louise Martin and all those who died or suffered in the U.S. Embassy bombing in Nairobi Kenya, July 1998. The authors thank Kent Wagoner for technical assistance.
1 Members of the World Health Organization (WHO) Hemorrhagic Fever Task Force, in addition to the listed authors, included Paul Arguin, David Ashford, Julianna Grant, Stuart Nichol, and Brian Plikaytis, Centers for Disease Control and Prevention; Marta Valenciano, European Program for Intervention Epidemiology Training, European Union; James N. Mwanzia, Philip Kangethe, Stephen A. Mileso, and Quinto Maloba, Kenya Ministry of Health; Manuela Dunster, Kenyan Medical Research Institute; Alan Kemp and Koos Coetzer, National Institutes of Virology, Sandringham, South Africa; Jean-Jacques Muyembe, Philip M. Mothoka, Gregory C. Gottlieb, John H. Bierke, and Glyn Davies, WHO, Geneva and African Regional Office; Saade Abdallah, International Federation of the Red Cross and Red Crescent; Elizabeth Nicore and Olivier West, Médècins du Monde; and Christine Grace Adhiambo, Africa Medical Research Foundation.
Dr. Woods is an Infectious Diseases and Medical Microbiology Fellow at Duke University. His interests include infectious disease outbreak investigations and diagnostic tests for emerging pathogens.